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We performed polysomnography on eight randomly chosen male patients who met Poser's criteria for definite multiple sclerosis (MS), to obtain an idea of the frequency and severity of sleep apnea (SA) in this population. Ages ranged from 27 to 67 years (mean, 50 years). The mean Kurtzke's disability score was 6.1. Only one complained of awakenings with shortness of breath. Otherwise, none had a history of sleep disorder or significant pulmonary disease. We found that two patients had an apnea index greater than 5, with oxygen desaturation to 60% in one. Two others had apnea indices less than 5, but had oxygen desaturation to 59% and 81% during the apneas. Two patients had apnea indices less than 5 without oxygen desaturation. The apneas were mainly central type, except in one who had a mixed central-obstructive pattern. These preliminary results suggest that SA in MS may be more frequent than suspected, and it can be associated to significant oxygen desaturation in some cases. The potential impact of SA in MS deserves further evaluation. Key Words: Sleep apnea&mdash;Multiple sclerosis&mdash;Automatic respiration&mdash;Central apneas&mdash;Apneas with central nervous system lesions.
Sleep apnea (SA) has been associated with a variety of systemic and neurological conditions (1, 2) , especially with cervicomedullary lesions (3) (4) (5) (6) . Autopsy and neuroradiological studies in multiple sclerosis (MS) patients often reveal demyelinating lesions in the cervicomedullary region (7, 8) . Neurons that regulate automatic respiration are located in the pons and medulla (9) (10) (11) . In spite of the frequent cervical spinal cord and brainstem lesions with MS, this disorder is often omitted or mentioned vaguely in reviews of SA. The potential impact that SA with recurrent oxygen desaturation could have in MS patients is uncertain. Furthermore, medications such as benzodiazepines commonly used to alleviate spasticity in MS patients are also potent suppressants of automatic respiration and aggravate SA (12) . We studied eight MS patients with polysomnography to obtain an idea of the frequency and severity of SA.
Patients and Methods
Eight MS patients participated in this approved clinical research protocol (see Table 1 for a summary of their clinical characteristics). They were the first eight patients who gave consent to be studied from the MS population of the VA Medical Center of Cleveland. Seven had no history of a sleep disorder. Patient 5 complained of awakening from night sleep with shortness of breath. All complained of mild to moderate daytime fatigue but not of sleepiness. None was morbidly obese, nor did any have significant pulmonary disease. All had a course characterized by multiple exacerbations and remissions and met Poser's criteria for definite MS (13) . The mean rating on Kurtzke's disability scale was 6.1 (14) . The patients were males, aged 27-67 years (mean, 50 years). Only The subjects were admitted to the hospital for 72 h. A history, medical examination, neurological examination, and review of old records were performed to document the MS diagnosis and to rule out pulmonary, nasopharyngeal, facial, or craniocervical anomalies that may have predisposed them to SA. A onenight polysomnogram was performed using standard techniques (15) (EMG), nasal and oral airflow using thermisters, chest and abdominal respiration, and oxygen saturation. Apneas were defined as cessation of respiration longer than 10 s. Central apnea (CA) implied no respira-tory effort from the chest or abdomen. With obstructive apneas (OA), there were paradoxical respiratory movements without airflow. Significant oxygen desaturation was defined as a drop of greater than 10 units from the baseline oxygen saturation (15) .
Results
A summary of the polysomnographic evaluations is shown in Table 2 . Six patients had SA. The apneas were central except for Patient 3, who had mixed central-obstructive apneas. Three patients showed significant oxygen desaturation of 59% (Patient 5), 60% (Patient 7), and 81% (Patient 6). The apnea durations lasted z101 s, with an average of 16.3 s. The range of apnea indices (number of apneas/hours of sleep) was 0.6-40, with an average of 9.4. The apneas occurred mainly during non-rapid eye movement (NREM) sleep for Patients 1, 5, 6, 7, and 8, and during REM for Patient 3. The sleep efficiency (number of minutes asleep/total minutes in bed X 100) was less than normal in all patients (range, 7.3-96.0%; mean, 55.5%). There was a relative decrease or absence of Stages III and IV, and REM sleep (16) . No cardiac arrhythmias occurred.
Patient 5 was treated with nocturnal low-flow oxygen and continuous positive airway pressure (CPAP). A second polysomnogram showed episodic decreases in the amplitude of respirations with no oxygen de- 
Discussion
We found SAs in six of eight patients with MS. Brief and infrequent episodes of CA without significant oxygen desaturation at sleep onset and during REM sleep has been reported in normal volunteers (17, 18) .
This could be the case for Patients 3, 6, and 8, who had apnea indices less than 5, without oxygen desaturation or cardiac arrhythmias. SA in these three patients had no clinical significance. However, three patients (Patients 1, 5, and 7) had clinically significant SA on the basis of large apnea index and oxygen desaturation during the apneas. Patient 5 had a good response to treatment. Patient _7 refused treatment. Although Patient 1 had an apnea index of 7.6, he did not develop oxygen desaturation or cardiac arrhythmias, and therefore he was not treated.
Three factors could have contributed to the presence of SA in these patients: ( (19) . Most of the apneas in our patients were central, suggesting the first hypothesis as the more likely mechanism. Also, obesity could have been an aggravating factor in Patient 7. More specific respiratory function testing, such as hypercarbic respiratory response (20) and the occlusion pressure response (21) , may help to elucidate the mechanism that leads to SA in MS. The sensitivity to C02 has been found to be decreased in MS (22) , which also supports our first hypothesis. The reduced sleep efficiency and decrease in Stages III and IV and REM sleep found in this study are more severe than the &dquo;first night effect&dquo; described in normal subjects (23) . It is possible that the neurological deficits in these patients do not allow them to adapt better to the new sleep environment. Further polysomnographic studies using two to three consecutive nights of adaptation will be of interest in evaluating this problem.
In this study, the findings in the neurological exam did not distinguish the patients with SA. The history was helpful in Patient 5. There was no correlation between the symptom of daytime fatigue and SA. These preliminary data suggest that a further study of SA in MS is needed. Many deaths in MS are attributed to pneumonia, without critical evaluation of respiratory function. Moreover, sudden death during sleep has been reported in MS (24, 25) . The use of medications such as benzodiazepines to alleviate spasticity could worsen SA. A sleep history should be part of the evaluation in MS patients; if suggestive of SA, a polysomnogram should be obtained before prescribing benzodiazepines. This is particularly important in the aging MS patient, as it is known that the prevalence of SA increases with aging. Consequently, a larger study including females, a wider range of age and disability, polysomnographic evaluation of at least three consecutive nights' duration, multiple sleep latency testing, and magnetic resonance imaging are needed to determine the prevalence and severity of SA in MS and to correlate them with neuroanatomical lesions, hypersomnolence, or fatigue. The results of such a study could help to identify those MS patients at risk of developing SA.
